Crossmark

Dose-response and infusion duration of intra-arterial nimodipine in cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a single-center case series

Crossref DOI link: https://doi.org/10.1007/s00234-025-03699-7

Published Online: 2025-07-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guenego, Adrien

Salim, Hamza Adel

Taccone, Fabio Silvio

Heit, Jeremy J.

Wang, Maud

Sadeghi, Niloufar

Ligot, Noémie

Lolli, Valentina

Yedavalli, Vivek

Wintermark, Max

Tannouri, Fadi

Lubicz, Boris
License Information

Text and Data Mining valid from 2025-07-16

Version of Record valid from 2025-07-16
More Information

Article History

Received: 31 January 2025

Accepted: 28 June 2025

First Online: 16 July 2025

Declarations

:

: The study was approved by the institutional review board of Erasme University Hospital under the SAVEBRAIN PWI protocol (NCT05276934). The study complied with the Declaration of Helsinki and HIPAA regulations.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below